Data / Form D filings / Orcosa Inc.
Orcosa Inc.: Form D filings
Orcosa Inc., a biotechnology company in Ewing, NJ, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on January 7, 2025, reports $11.3 million sold of a $11.3 million offering to 36 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7 Graphics Drive, Ewing, NJ, 08628
- Phone
- (201) 248-7100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1852165
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Amendment | $11,290,750 | $11,290,750 | 36 | Sep 27, 2021 | sec.gov | |
| Jan 7, 2025 | New notice | $15,521,640 | $7,275,000 | $8,246,640 | 17 | Dec 23, 2024 | sec.gov |
| Oct 12, 2021 | New notice | $3,529,800 | $3,529,800 | 3 | Sep 27, 2021 | sec.gov | |
| Mar 19, 2021 | New notice | $37,925,000 | $37,925,000 | 50 | Mar 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert M. Pollaro | Director, Executive Officer | |
| Vincent ` Mileto | Director, Executive Officer | |
| Bryan ` Ridall | Director, Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Jan 6, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Orcosa Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.